CRISPR, FDA-approved gene therapies, partial epigenetic reprogramming, OSK factors, ER-100, telomerase and the frontier of cellular rejuvenation.
Readers who hear age-reversal gene therapy claims and need the line between approved therapies, registered trials and frontier research.
Gene therapy is real medicine in specific diseases; consumer age-reversal gene therapy is a much more speculative claim.
Partial reprogramming tries to reset aspects of cell state without erasing identity, but it remains frontier biology.
OSK refers to three reprogramming factors often discussed in cellular rejuvenation research.
Approved gene therapies are specific products for specific diseases; anti-aging gene therapy claims need separate evidence and regulatory scrutiny.
FDA
Jun 27, 2026
The FDA approved-product list is the anchor for separating real gene therapy products from consumer rejuvenation claims.
Approved products can validate a platform category while still saying nothing about broad anti-aging offers.
No. Approved gene therapies are evaluated for specific diseases, products and populations; that does not validate consumer age-reversal offers.